Holen Sie sich die Stockscreener-App
13.33
0.89%
-0.12
Schlusskurs vom Vortag:
$13.45
Offen:
$13.51
24-Stunden-Volumen:
1.31M
Relative Volume:
1.18
Marktkapitalisierung:
$1.04B
Einnahmen:
$1.64B
Nettoeinkommen (Verlust:
$-495.80M
KGV:
-2.0815
EPS:
-6.404
Netto-Cashflow:
$-45.25M
1W Leistung:
+1.18%
1M Leistung:
-14.50%
6M Leistung:
+26.71%
1J Leistung:
-16.06%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$13.10
$13.83
52-Wochen-Spanne:
$8.70
$20.49
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Firmenname
Integra Lifesciences Holdings Corp
Sektor
Branche
Telefon
(609) 275-0500
Adresse
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
13.33 | 1.04B | 1.64B | -495.80M | -45.25M | -6.404 |
ABT
Abbott Laboratories
|
102.45 | 177.28B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.63 | 121.04B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
304.40 | 116.76B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.58 | 66.06B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
88.29 | 50.89B | 6.30B | 1.07B | 1.09B | 1.8406 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-07-28 | Eingeleitet | UBS | Neutral |
| 2026-07-09 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2026-06-18 | Hochstufung | Argus | Hold → Buy |
| 2026-05-28 | Hochstufung | Citigroup | Sell → Neutral |
| 2026-04-15 | Herabstufung | Argus | Buy → Hold |
| 2025-03-31 | Hochstufung | Argus | Hold → Buy |
| 2024-12-02 | Eingeleitet | Morgan Stanley | Underweight |
| 2024-10-07 | Hochstufung | BTIG Research | Sell → Neutral |
| 2024-07-30 | Herabstufung | BTIG Research | Neutral → Sell |
| 2024-07-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2024-05-07 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-05-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-12-05 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | Eingeleitet | CL King | Buy |
| 2023-08-24 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-08 | Herabstufung | Argus | Buy → Hold |
| 2023-05-24 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-07-25 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2021-12-17 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-09-15 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-05-27 | Eingeleitet | Citigroup | Neutral |
| 2020-04-03 | Eingeleitet | SunTrust | Buy |
| 2020-01-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | Eingeleitet | SunTrust | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-08-07 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | Hochstufung | BTIG Research | Neutral → Buy |
| 2018-07-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2018-01-02 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-05-02 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | Eingeleitet | UBS | Buy |
Alle ansehen
Integra Lifesciences Holdings Corp Aktie (IART) Neueste Nachrichten
Precision Trading with Integra Lifesciences Holdings Corporation (IART) Risk Zones - Stock Traders Daily
Integra Announces Completion of Refinancing Transactions - GlobeNewswire
Press Release Distribution & Media Outreach Platform for PR Agencies - ACCESS Newswire
Will Flood Driven Guidance Cut Change Integra LifeSciences Stock Narrative - Simply Wall Street
Integra LifeSciences Holdings (IART) Prices 9.5% Notes, Is The Repair Story Still Undervalued? - Simply Wall Street
Integra LifeSciences to Showcase ENT Portfolio and Support New Clinical Research at AAO-HNSF Annual Meeting - Quiver Quantitative
Integra LifeSciences to Highlight ENT and Instruments - GlobeNewswire
New research on balloon treatment alongside surgery for chronic ear disease will be presented - Stock Titan
Truist cuts target for Integra LifeSciences stock to USD 15.00 - ad-hoc-news.de
Press Release Distribution & Media Outreach Platform for PR Agencies - ACCESS Newswire
Truist Securities Adjusts Integra LifeSciences Price Target to $15 From $19 - Yahoo Finance
INTEGRA LIFESCIENCES HOLDINGS CORPORATION IART INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 21.2% Share Drop - Business Wire
Integra LifeSciences (IART) 10K Form and Latest SEC Filings 2026 - MarketBeat
Integra Lifesciences Holdings Corp (IART) Shares Surge 4.0% -- W - GuruFocus
What Is Integra LifeSciences Holdings (IART) $450 Million Debt Deal Changing? - Simply Wall Street
Integra LifeSciences Holdings Corporation at Morgan Stanley Global Healthcare Conference Transcript - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Encourages Integra LifeSciences Holdings Corporation (IART) Investors to Inquire about Securities Investigation - ACCESS Newswire
Integra LifeSciences (IART) Prices $450M Senior Secured Notes Ma - GuruFocus
Integra LifeSciences prices $450M senior secured notes at 9.5% - Investing.com
Integra LifeSciences Prices $450 Million of 9.500% Senior Secured Notes Due 2033 - Quiver Quantitative
Integra Announces Pricing of Senior Secured Notes - GlobeNewswire
$450 million in Integra LifeSciences notes carry a 9.5% rate - Stock Titan
Integra LifeSciences Holdings (IART) Resets Guidance As The Undervalued Narrative Faces A Fresh Test - Simply Wall Street
A Look at Integra Lifesciences Holdings Corp (IART) After 3.1% G - GuruFocus
Integra LifeSciences Holdings (IART) Cuts 2026 Revenue Outlook, Is The Stock Below Fair Value? - Yahoo Finance
Wells Fargo cut its target for Integra LifeSciences stock to USD 15.00 - AD HOC NEWS
Integra LifeSciences stock cuts guidance after Cincinnati flooding - AD HOC NEWS
BMO cuts target for Integra LifeSciences stock to USD 15 - AD HOC NEWS
INTEGRA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026 - GlobeNewswire
Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026 - GlobeNewswire
How Investors Are Reacting To Integra LifeSciences Holdings (IART) Full Year Revenue Cut - Simply Wall Street
Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026 - Yahoo Finance
INTEGRA LIFESCIENCES HOLDINGS CORPORATION INVESTIGATION: - GlobeNewswire
Flood Damage Prompts Integra LifeSciences To Revise 2026 Outlook - Benzinga
BMO cuts Integra LifeSciences stock price target on facility disruption - Investing.com
Integra LifeSciences (NASDAQ: IART) Investor Alert: Johnson - GlobeNewswire
Wells Fargo cuts Integra LifeSciences price target on lower revenue outlook - Investing.com
Is Integra Lifesciences Holdings Corp (IART) a Bargain After 21. - GuruFocus
Why Integra LifeSciences (IART) Stock Is Nosediving - Yahoo Finance
Integra LifeSciences (IART) Shares Plunge Nearly 21% Following Q - GuruFocus
Integra LifeSciences plunges 21% on preliminary Q3 results (IART:NASDAQ) - Seeking Alpha
Integra LifeSciences Q3FY26 Results: Guidance cut on flood impact - scanx.trade
Stock Market Midday, Oct. 2: Stocks Rally as Weak Jobs Data Cools Fed Rate Hike Bets - The Motley Fool
Integra LifeSciences Holdings Corporation Announces Launch Of $600 Million Senior Secured Term Loan B - marketscreener.com
Why is Integra LifeSciences stock tumbling today? - Investing.com
Integra LifeSciences stock tumbles after cutting 2026 outlook - Investing.com
Integra LifeSciences proposes $600M term loan refinancing By Investing.com - Investing.com Nigeria
Integra LifeSciences cuts 2026 guidance after flooding impact - Investing.com
Integra slips after guidance cut due to flooding event - Seeking Alpha
Finanzdaten der Integra Lifesciences Holdings Corp-Aktie (IART)
Umsatz
Nettogewinn
Free Cashflow
ENV
Integra Lifesciences Holdings Corp-Aktie (IART) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 10 '26 |
Option Exercise |
0.00 |
1,216 |
0 |
23,152 |
| Poul Mojdeh | President & CEO |
Jan 06 '26 |
Option Exercise |
0.00 |
1,390 |
0 |
1,390 |
| GRAVES JEFFREY A | Director |
Nov 05 '25 |
Buy |
11.35 |
9,000 |
102,150 |
41,086 |
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Oct 12 '25 |
Option Exercise |
0.00 |
11,965 |
0 |
25,217 |
0.37%
6.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):